|
Jindal Steel & Power Ltd (JSPL) saw a 14% drop in share price to Rs 724 following a 51% year-on-year decline in net profit to Rs 951 crore for Q3. Weak steel prices and cheaper imports impacted earnings, despite a 5% rise in sales volume. EBITDA fell 24%, with revenues flat at Rs 13,707 crore.
Category:
News and Media
New drug suzetrigine, known by its brand name Journavx, has been approved to treat moderate to severe pain.
Category:
News and Media
A growth-focused budget that stimulates spending and addresses fiscal priorities could drive market sentiment and set the stage for FY26 growth.
Category:
News and Media
All news |
||||||||||||||||||
|